Remove keyword diabetes
article thumbnail

Grand Rounds March 1, 2024: Effect of an Intensive Food-As-Medicine Program on Health and Health Care Use: Evidence from a Randomized Clinical Trial (Joseph Doyle, PhD)

Rethinking Clinical Trials

Schell Professor of Management and Applied Economics MIT Sloan School of Management Slides Keywords Food-as-Medicine, Randomized Clinical Trial, Diabetes Key Points Diabetes is common and costly. Food insecurity is associated with diabetes.              Speaker Joseph Doyle, PhD Erwin H. 9% of the U.S.

article thumbnail

Grand Rounds July 14, 2023: Lessons From the COORDINATE-Diabetes Trial (Christopher B. Granger, MD; Neha J. Pagidipati, MD, MPH)

Rethinking Clinical Trials

The objective of COORDINATE-Diabetes trial was to improve the implementation and adoption of these therapies by testing the impact of a clinic-level, multifaceted intervention on the prescription of 3 key groups of evidence-based therapies. in which participants had type 2 diabetes mellitus and ASCVD.

Trials 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Grand Rounds December 2, 2022: A Randomized Controlled Trial of Mobile Health Intervention in Heart Failure and Diabetes: Lessons Learned (G. Michael Felker, MD, MHS)

Rethinking Clinical Trials

Pragmatic Clinical Trials, Heart Failure, Diabetes. that focused on patients with heart failure and diabetes, two rapidly growing conditions that are highly morbid. The post Grand Rounds December 2, 2022: A Randomized Controlled Trial of Mobile Health Intervention in Heart Failure and Diabetes: Lessons Learned (G. Key Points.

Trials 130
article thumbnail

Grand Rounds July 8, 2022: Results From the COVID-OUT Trial, A Phase-3 Trial of Outpatient Treatment for Covid-19 Using Metformin, Ivermectin, and Fluvoxamine (Carolyn Bramante, MD, MPH; Thomas Murray, PhD; Jared Huling, PhD)

Rethinking Clinical Trials

University of Minnesota School of Public Health. Jared Huling, PhD. Assistant Professor of Biostatistics. Division of Biostatistics. University of Minnesota School of Public Health. COVID-19, COVID-OUT. Key Points.

Trials 130
article thumbnail

Grand Rounds Ethics and Regulatory Series February 10, 2023: Informing and Consenting: What Are the Goals? (P. Pearl O’Rourke, MD; David S. Wendler, PhD, MA; Miguel Vazquez, MD; P. Michael Ho, MD, PhD)

Rethinking Clinical Trials

ICD-Pieces studied patients with chronic kidney disease (CKD), diabetes and hypertension. If you are notifying, when do you offer an opt-out option and what do you do when potential subjects have questions or do not want to be in the research? The intervention was to facilitate delivery of guideline-based care.

article thumbnail

Grand Rounds September 16, 2022: Using Nationwide Registries to Conduct Pragmatic Randomized Trials: The DANFLU Program (Tor Biering-Sørensen, MD, PhD, MPH)

Rethinking Clinical Trials

Another trial is called NUDGE-DM using the same system for identifying patients with diabetes to test communication strategies for optimizing the use of guideline directed medical therapy for T2D patients with established CVD. Faculty of Health and Medical Sciences. University of Copenhagen. Department of Cardiology. Key Points.

Trials 130